camptothecin has been researched along with nocodazole in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Akula, B; Bharathi, EV; Billa, VK; Cosenza, SC; Gallo, JM; Lv, H; Mallireddigari, MR; Padgaonkar, A; Pallela, VR; Reddy, EP; Reddy, MV; Subbaiah, DR | 1 |
| Lee, H; Srivastava, V | 1 |
| Cao, SL; Ding, PP; Gao, M; Li, J; Li, Z; Li, ZF; Liao, J; Liu, CH; Mao, BB; Wang, H; Xu, X; Yang, CR; Zhao, H | 1 |
| Cao, SL; Jiang, W; Li, J; Li, YS; Li, Z; Liao, J; Peng, B; Ren, TT; Wang, FC; Wang, G; Wang, H; Xu, S; Xu, X; Yang, CR | 1 |
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Durka, S; Hueber, A; Weller, M | 1 |
| Fan, S; Gupta, M; Kohn, KW; O'Connor, PM; Pommier, Y; Zhan, Q | 1 |
| Hawes, JJ; Nerva, JD; Reilly, KM | 1 |
| Anderson, S; Baker, SP; Grant, PA; Hunt, DF; Phillips, J; Qiu, Q; Shabanowitz, J; Smith, MM; Yates, JR | 1 |
| Ascenzi, S; Cundari, E; De Santis Puzzonia, M; Degrassi, F; Gonzalez, L | 1 |
1 review(s) available for camptothecin and nocodazole
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
11 other study(ies) available for camptothecin and nocodazole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Design; Drug Resistance, Neoplasm; HCT116 Cells; Humans; K562 Cells; MCF-7 Cells; Mice; Mice, Nude; Microtubules; Neoplasms; Polymerization; Sulfonamides; Tubulin; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Neoplasms; Quinolines; Stilbenes; Tubulin; Tubulin Modulators | 2015 |
Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Quinazolinones; Structure-Activity Relationship; Thiocarbamates | 2016 |
Synthesis, cytotoxic evaluation and target identification of thieno[2,3-d]pyrimidine derivatives with a dithiocarbamate side chain at C2 position.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Thiocarbamates; Tumor Cells, Cultured | 2018 |
CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aphidicolin; Apoptosis; Camptothecin; Cell Cycle; Cell Death; Cisplatin; Culture Media, Serum-Free; Doxorubicin; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Gene Expression; HeLa Cells; Humans; Hydroxyurea; Jurkat Cells; Membrane Glycoproteins; Nimustine; Nocodazole; Paclitaxel; Sensitivity and Specificity; Teniposide; Tumor Cells, Cultured; Vincristine | 1998 |
Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Colonic Neoplasms; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Flow Cytometry; G1 Phase; Genes, p53; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nocodazole; Oncogene Proteins, Viral; Recombinant Fusion Proteins; Repressor Proteins; Topoisomerase I Inhibitors; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 1997 |
Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Camptothecin; Cytostatic Agents; Cytotoxins; Drug Evaluation, Preclinical; Genes, Reporter; Humans; Nocodazole; Reproducibility of Results | 2008 |
Histone H3 Thr 45 phosphorylation is a replication-associated post-translational modification in S. cerevisiae.
Topics: Acetylation; Amino Acid Substitution; Camptothecin; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; DNA Replication; Histones; Hydroxyurea; Intracellular Signaling Peptides and Proteins; Lysine; Mutation; Nocodazole; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Recombinant Proteins; S Phase; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Threonine | 2010 |
Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication.
Topics: Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Line; Cell Proliferation; Cellular Senescence; Checkpoint Kinase 1; Chromosomal Instability; Cytokinesis; DNA Replication; Fibroblasts; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Humans; Mitosis; Nocodazole; Protein Kinases; Signal Transduction; Tetraploidy; Tumor Suppressor Protein p53 | 2016 |